Acadia’s Trofinetide Shows Efficacy In Rett Syndrome, But Safety Looks Shaky

 
• By Joseph Haas
  
Diagnosis Rett syndrome, pills and stethoscope.
Acadia's Phase III data could position trofinetide for first drug approval in Rett syndrome
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D